Hypertension Management for the Prevention of Heart Failure: Best Strategies
- 57 Downloads
Purpose of Review
Heart failure (HF) is a growing epidemic that can be prevented. Since hypertension is one of the most prevalent medical conditions and leading causes of morbidity and mortality, aggressive treatment is essential, especially for those at risk for HF.
There has been significant evidence developed over the past decade highlighting the necessity for rigid blood pressure management; with more recent guidelines addressing the importance of preventing hypertension from progressing to HF.
In this review, we discuss hypertension management strategies as a preventative tool for HF development.
KeywordsHeart failure Hypertension Prevention Left ventricular hypertrophy
Compliance with Ethical Standards
Conflict of Interest
Estefania Oliveros, Karolina Marinescu, Tisha Suboc, and Kim Williams declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014;63(4):878–85.CrossRefPubMedGoogle Scholar
- 9.McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787–847.CrossRefPubMedGoogle Scholar
- 15.Butler J, Kalogeropoulos AP, Georgiopoulou VV, Bibbins-Domingo K, Najjar SS, Sutton-Tyrrell KC, et al. Systolic blood pressure and incident heart failure in the elderly. The cardiovascular health study and the health, ageing and body composition study. Heart. 2011;97(16):1304–11.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure National Registry (ADHERE). Am Heart J. 2005;149(2):209–16.CrossRefPubMedGoogle Scholar
- 20.Shah SJ, Aistrup GL, Gupta DK, O'Toole MJ, Nahhas AF, Schuster D, et al. Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure. Am J Physiol Heart Circ Physiol. 2014;306(1):H88–100.CrossRefPubMedGoogle Scholar
- 24.Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation. 2006;113(17):2089–96.CrossRefPubMedGoogle Scholar
- 29.Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.CrossRefPubMedGoogle Scholar
- 30.Hunt SA. American College of C, American Heart Association task force on practice G. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46(6):e1–82.CrossRefPubMedGoogle Scholar
- 31.Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115(12):1563–70.CrossRefPubMedGoogle Scholar
- 33.• Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017. The 2017 guideline is a comprehensive guideline incorporating new information from studies regarding blood pressure (BP)-related risk of cardiovascular disease (CVD) and provide the reader with guidance for initiation of antihypertensive drug treatment, BP goals of treatment, strategies to improve hypertension treatment and control, and various other important issues. Google Scholar
- 36.Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens. 2016;34(4):613–22.CrossRefPubMedGoogle Scholar
- 51.Johnson CB, Beanlands RS, Yoshinaga K, Haddad H, Leech J, de Kemp R, et al. Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol. 2008;24(9):697–704.CrossRefPubMedPubMedCentralGoogle Scholar
- 53.Huelsmann M, Neuhold S, Resl M, Strunk G, Brath H, Francesconi C, et al. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial. J Am Coll Cardiol. 2013;62(15):1365–72.CrossRefPubMedGoogle Scholar
- 54.Conlon CM, Dawkins I, O’Loughlin C, Gibson D, Kelleher CC, Ledwidge M, et al. B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent’s Screening TO Prevent Heart Failure) study. Clin Chem Lab Med. 2011;49(4):719–28.CrossRefPubMedGoogle Scholar
- 61.He FJ, Burnier M, Macgregor GA. Nutrition in cardiovascular disease: salt in hypertension and heart failure. Eur Heart J. 2011;32(24):3073–80Google Scholar
- 69.Lara K. Dietary patterns and incident heart failure in adults with no known coronary disease or heart failure: the REGARDS Cohort. AHA; 2017: Circulation; 2017. p. A15448.Google Scholar
- 82.Officers A. Coordinators for the ACRGTA, lipid-lowering treatment to prevent heart attack T. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288(23):2981–97.CrossRefGoogle Scholar